DiagnaMed Launches a Generative Artificial Intelligence Medical Chatbot, Dr. GenAI

June 15, 2023

TORONTO, June 15, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB:DGNMF), a generative AI healthcare company, is pleased to announce the launch of Dr. GenAI (https://drgen.ai), a generative artificial intelligence (“GenAI”) medical chatbot powered by OpenAI’s ChatGPT for people seeking to take control of their overall health. Dr. GenAI is the Company’s third commercial product from its Health GenAI division, which is focused on developing and commercializing a suite of generative AI health applications.

Read more at globenewswire.com

Related news for (DGNMF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.